A New Zealand company is producing a probiotic feed additive system (including a starter and finisher product) for use between birth and weaning which claims to improve rumen development and feed conversion of the calf. It also claims to provide an increase in the yield of milk solids produced by the animal during subsequent lactations.
A patented, portable, low cost sensor for the detection of very low levels of chemical analytes in liquids such as urine or saliva. Based on functionalised nanoparticles which emit an electrical signal on binding of the analyte, the technology could have the potential to be developed for use as an animal side test to detect and identify infective diseases or reproductive status in production animals.
Patented hollow silica-based microcapsule technology that can be used to deliver vaccines in animals. The microcapsules also act as an adjuvant with proof of concept demonstrated in a mouse model of bovine viral diarrhea. The microcapsules are cheap to produce using known manufacturing techniques and can be customized to suit differing actives.
Hollow silica based microcapsule technology that can be used to deliver a range of antibiotic molecules. Potential applications include antibiotic delivery as an oral, topical or as feed additive treatment. The microcapsules have small hair-like silica protrusions on their surface that have been shown to enable the microcapsule to bind to the bacterial cell wall providing enhanced activity. In vitro trials of encapsulated lysozyme (a natural antibiotic) have shown 100% inhibition of E coli (compared to 57% with conventional microcapsules). The vesicles can be customized to suit differing actives.
Hollow silica-based microcapsule technology that can be used to deliver a range of small molecules targeting animal ectoparasites with proof of concept to date shown against cattle tick larvae. The microcapsules have small hair-like silica protrusions on their surface that have been shown to enhance retention on the animals hide, have enhanced UV stability and are cheap to produce using known manufacturing techniques. The vesicles can be customized to suit a range of different actives.
A technology that allows farmers to rapidly (12-18hrs) identify the causative agent in mastitic cows, and make informed and timely decisions on appropriate follow-on actions. The technology is designed to be used on-farm and utilises a simple and easy to use plate system. An opportunity exists for a third party to acquire rights to the technology.
A novel class of molecules that could be developed further as drugs for the treatment of cryptosporidiosis in animals (or humans). This new class of molecules are simple to make, cheap and have been shown to be as active as the current industry standard nitaoxaninide in in vitro trials. An opportunity exists for a third party to acquire rights to this technology.
Technology for the humane castration and docking of lambs (and calves) that addresses animal welfare issues. Development and on farm trials in lambs has been completed with a calf trial expected next. Product provides a simple cheap alternative to existing methods. An opportunity exists for collaboration, investment or acquisition.
The company has developed patented devices (worn on the collar) for monitoring animal health and wellbeing. The company has sold more than 500 units in the US, Australia and New Zealand.
Australian company that has a patented chemical and enzyme free process for extracting dietary fibre from agricultural crops. This company could be a provider of ingredients to boost the fibre content of petfoods and reduce meat content, fat, and calories.